Dexcom EVP Sells $226K in Company Stock Under Pre-Arranged Plan
DEXCOM INC
Subscribe to track DXCM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Dexcom (DXCM) Insider Transaction Insider: Sadie Stern (EVP Chief People & Culture Off) Action: Sale Shares: 2,565 at $88.37/share Total Value: $226,668.45 Date: 2026-08-27 Remaining Shares: 126,043 This transaction was executed under a Rule 10b5-1 trading plan adopted on May 28, 2026.
Comprehensive Analysis
On August 27, 2026, Sadie Stern, the Executive Vice President and Chief People & Culture Officer of Dexcom, sold 2,565 shares of common stock at a price of $88.37 per share, for a total transaction value of approximately $226,668. Following this sale, Ms. Stern directly owns 126,043 shares of Dexcom. This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on May 28, 2026. Such plans allow insiders to establish pre-arranged plans to sell company stock, providing an affirmative defense against accusations of trading on non-public information. The remaining shares include 71,903 unvested restricted stock units (RSUs) with various vesting schedules extending to 2029.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.